Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 3/20 | 0.64 |
| ▸ | CCR5 | P51681 | 3/20 | 0.64 |
| ▸ | CCR8 | P51685 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | MMP2 | P08253 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | GMNN | O75496 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | MMP9 | P14780 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.64 |
| ▸ | MMP8 | P22894 | 1/20 | 0.64 |
| ▸ | THPO | P40225 | 1/20 | 0.64 |
| ▸ | MTOR | P42345 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15497974 | 1.00 | CCR1 (0.64) | CCR1CCR5CCR8LMNAMMP2 | |
| SCHEMBL13311147 | 0.90 | CCR1 (0.61) | CCR1CCR5CCR8LMNAMMP2 | |
| SCHEMBL19767983 | 0.90 | KDM4E (0.52) | CCR1CCR5CCR8LMNAMMP2 | |
| SCHEMBL22101153 | 0.88 | CCR1 (0.64) | CCR1CCR5CCR8LMNAMMP2 | |
| SCHEMBL14900783 | 0.88 | LMNA (0.64) | CCR1CCR5CCR8LMNAMMP2 | |
| SCHEMBL12853992 | 0.88 | LMNA (0.64) | CCR1CCR5CCR8LMNAMMP2 | |
| SCHEMBL9380551 | 0.88 | AR (0.54) | CCR1CCR5CCR8LMNAMMP2 | |
| SCHEMBL30515654 | 0.88 | CCR1 (0.62) | CCR1CCR5CCR8LMNAMMP2 | |
| SCHEMBL2922581 | 0.88 | CCR1 (0.62) | CCR1CCR5CCR8LMNAMMP2 | |
| SCHEMBL22101154 | 0.87 | CCR1 (0.76) | CCR1CCR5CCR8LMNAMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111208077-A | Device for on-line testing of ferrous iron and total iron content in sample and use method | 中国科学院地质与地球物理研究所 | 2020-05-29 | — | — | CN | claimed |
| CN-111208077-B | Device for on-line testing of ferrous iron and total iron content in sample and use method | 中国科学院地质与地球物理研究所 | 2021-01-22 | — | — | CN | disclosed |
| CN-111208077-A | Device for on-line testing of ferrous iron and total iron content in sample and use method | 中国科学院地质与地球物理研究所 | 2020-05-29 | — | — | CN | disclosed |
| US-20200054647-A1 | RUTHENIUM COMPLEXES FOR TREATING CANCER WHICH COMPRISES CANCER STEM CELLS | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2020-02-20 | — | — | US | disclosed |
| EP-3539971-A1 | RUTHENIUM COMPLEXES FOR TREATING CANCER WHICH COMPRISES CANCER STEM CELLS | Universidade de Santiago de Compostela (ES) | 2019-09-18 | — | — | EP | disclosed |
| WO-2018087413-A1 | RUTHENIUM COMPLEXES FOR TREATING CANCER WHICH COMPRISES CANCER STEM CELLS | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2018-05-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200054647-A1 | RUTHENIUM COMPLEXES FOR TREATING CANCER WHICH COMPRISES CANCER STEM CELLS | MYC, MYCBP, MCL1 | CCR1 3259/4885CCR5 1575/4885CCR8 3661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.